Great suggestion! We just submitted there earlier this month and unfortunately were not successful. Hoping for success with a different journal!

This came up recently for me and Jeff though with NTM… The easy answer might be ampho but of course has its own issues. Short of throwing our hands up, we were leaning rifabutin/posa vs. withholding treatment for NTM while managing aspergillosis and resume later.Then I went on vacation for a week 😂

We employed a collegial approach in this initiative - The e-message was not associated with any patient chart, nor did it challenge specific antibiotic decisions. The purpose is purely to make clinicians aware that their patient later developed C diff and encourage reflection on antibiotic use